Minerva Neurosciences
NERV
84 hedge funds and large institutions have $200M invested in Minerva Neurosciences in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
2% more funds holding
Funds holding: 82 → 84 (+2)
0.14% more ownership
Funds ownership: 9.42% → 9.56% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less capital invested
Capital invested by funds: $367M → $200M (-$166M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.49M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$2.68M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$1.41M |
| 4 |
Renaissance Technologies
New York
|
+$1.36M |
| 5 |
Morgan Stanley
New York
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$3.07M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.58M |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$1.76M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.36M |
| 5 |
JG
Jefferies Group
New York
|
-$952K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Russell Investments Group
London,
United Kingdom
| $28K | -$1.36M | -18,544 | -97% |
|
77
Barclays
London,
United Kingdom
| $22K | -$75.8K | -1,036 | -71% |
|
78
Canada Life
Winnipeg,
Manitoba, Canada
| $18K | – | – | – |
|
|
AIP
79
Ameritas Investment Partners
Lincoln,
Nebraska
| $15K | – | – | – |
|
80
Group One Trading
Chicago,
Illinois
| $12K | – | – | – |
|
81
UBS Group
Zurich,
Switzerland
| $7K | -$1.98K | -27 | -18% |
|
82
Daiwa Securities Group
Tokyo,
Japan
| $1K | – | – | – |
|
|
AIM
83
Anchor Investment Management
Columbia,
South Carolina
| $674 | – | – | – |
|
84
BNP Paribas Financial Markets
Paris,
France
| $67 | -$10.2K | -139 | -99% |
|
|
FPC
85
Falcon Point Capital
San Francisco,
California
| – | -$351K | -3,492 | Closed |
|
86
Walleye Trading
New York
| – | -$226K | -2,250 | Closed |
|
|
JT
87
Jump Trading
Chicago,
Illinois
| – | -$142K | -1,413 | Closed |
|
|
KAM
88
Kazazian Asset Management
Fort Lauderdale,
Florida
| – | -$126K | -1,253 | Closed |
|
89
Simplex Trading
Chicago,
Illinois
| – | -$25.5K | -348 | Closed |
|
90
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -75 | Closed |
|
NERV Hedge Fund Activity: Q4 2018 in Review
84 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2018, worth a combined $200M — down 45% from $367M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NERV positions and 6 closed out — a net gain of 2 holders — while 31 added to existing stakes and 25 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $4.49M. The largest seller was Marshall Wace North America, cutting an estimated $3.07M.
- 84 institutional investors held Minerva Neurosciences (NERV) as of Q4 2018, up from 82 in Q3 2018.
- Funds reported $200M of Minerva Neurosciences stock for Q4 2018, down 45% quarter-over-quarter.
- 8 funds opened new Minerva Neurosciences positions in Q4 2018 and 6 closed out, a net change of +2 holders.
- The largest Minerva Neurosciences buyer in Q4 2018 was Wellington Management Group, an estimated $4.49M added.
- The largest Minerva Neurosciences seller in Q4 2018 was Marshall Wace North America, an estimated $3.07M sold.
Based on aggregated 13F filings for Q4 2018.